Wimbledon Clinics

Wimbledon Clinics

Researchers Find Evidence Of SFPN In Fibromyalgia Patients

Contact us for an appointment

*At Wimbledon Clinics we comply with the provisions of the General Data Protection Regulations (GDPR) and the Data Protection Act (UK). We will never share your data without your permission and we will only use your data how you’ve asked us to. Please let us know if you’d like to join our mailing list to receive updates about our specialist consultants, the latest treatments for orthopaedic and sports injuries and prevention tips for common injuries.

For more information, click here to view our privacy policy

Fibromyalgia is estimated to affect up to 5% of people in Western countries. It is a condition characterised by chronic soft tissue pain, fatigue and sleep disturbances. The problem is that the causes of fibromyalgia remain unknown and there are few effective treatments. However, a study conducted at Massachusetts General Hospital (MGH) has found a connection between fibromyalgia and small-fibre polyneuropathy (SFPN).

About half of the fibromyalgia patients recruited for the study had damaged nerve fibres in their skin. The researchers also found other evidence of the presence of SFPN. What makes this discovery important is the fact that the two conditions share many symptoms but, in contrast to fibromyalgia, SFPN has an established pathology and its causes are known. Some of the specific medical conditions triggering SFPN are curable, for example Hepatitis C virus infection. Anne Louise Oaklander, corresponding author of the study, pointed out that the results were among the first objective evidence of an underlying mechanism in some fibromyalgia cases. Having an idea of the cause is the stepping stone to discovering better treatments, she added.

The MGH research team selected 27 adults suffering from fibromyalgia and 30 healthy subjects for a control group. The SFPN diagnostic process involved physical examination and questionnaires to assess neuropathy, as well as skin biopsies and tests of autonomic functions. The analysis of the data showed that 13 fibromyalgia patients had significantly reduced nerve fibre density, autonomic function tests deviating from the norm or both, which pointed to the presence of SFPN.

But given the complexity of fibromyalgia, one explanation will not do for all patients, Oaklander pointed out. Further research needs to focus on the subjects who did not exhibit signs of SFPN so that other causes can be found.